Search

everythinglearnresearchcommunity

for

Search:↓

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Cyproterone acetate can cause rare shortness of breath in women.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Hirsutism causes significant psychological distress in women.

Most female students at Qassim University know about PCOS, but there are still misunderstandings about it.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

A man's health improved after treating his undiagnosed adrenal insufficiency, which caused fatigue and weight loss.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

A woman with type 2 diabetes developed alopecia areata, suggesting a link between the two autoimmune conditions.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.